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1. Introduction 
There is a substantial amount of data supporting 
the view that the myelination defect in the Jimpy 
mutation is accompanied by a disturbance of glyco- 
lipid biosynthesis in the central nervous system 
(CNS). Cerebrosides and sulphatides, important 
glycolipid components of the myelin sheath, are 
significantly reduced in Jimpy brain [l-3] . The in- 
corporation of galactose-14C in uivo into cerebrosides 
and sulphatides is much lower in Jimpy brain than 
in normal controls [4-61. Further, there is a marked 
decrease of a galactosyltransferase catalyzing the 
transfer of galactose from UDPgalactose to sphingos- 
ine to give galactosyl-sphingosine @sychosine) [S, 71. 
The activity of this enzyme was also decreased in 
Quaking mouse, another mutant with defective 
myelination [8]. This finding was of particular in- 
terest since psychosine is considered as an inter- 
mediate in the postulated pathway of cerebroside 
biosynthesis [9, lo] . 
Ceramide was active as the acceptor of both 
glucose and galactose from their nucleotide deriva- 
tives in the presence of glycosyltransferases from 
embryonic chicken brain [ 1 l] . The presence of a 
galactosylceramide transferase (UDP-galactose:cera- 
mide galactosyl transferase) has also been reported in 
mouse brain [ 121 . The enzyme was active only with 
ceramide containing hydroxy fatty acids. The follow- 
ing reaction catalyzed by this enzyme was proposed 
as a possible route of cerebroside synthesis in brain 
[12] : 
North-Holland Publishing Company - Amsterdam 
HFA-ceramide* t UDP-galactose + HFA-cerebros- 
ide + UDP 
In the present work experiments with 15 to 19-day 
old Jimpy and control mice have demonstrated a very 
pronounced decrease of the galactosyl-ceramide 
transferase activity in mutant brain. 
2. Materials and methods 
Ceramides were prepared from beef brain cere- 
brosides [ 131 and purified by the silicic acid column 
chromatography and crystallization from ethyl 
acetate. HFA-Ceramides were separated from NFA- 
ceramides by TLC on silica gel G with chloroform- 
acetone-ethanol-ammonia-water (70:40:6: 1: 1, v/v) 
as developing solvent. Only sphingosine and hydroxy 
fatty acids were detected by TLC in the hydrolysis 
products after treatment of this material with metha- 
nolic KOH [ 131. The origins of standard lipids, 
labelled sugar nucleotide and other reagents were 
as described in previously published papers [5,7] . 
For experiments with subcellular fractions, a 10% 
brain homogenate of 19-day old mice in 0.32 M su- 
crose containing 1 mM EDTA was centrifuged at 
800 g for 10 min to remove nuclei and cell debris. 
* Abbreviations: 
HFA, hydroxy fatty acids 
NFA, non-hydroxy fatty acids 
TLC, thin-layer chromatography. 
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The crude mitochondrial fraction was then sedi- 
mented by centrifuging at 13,500 g for 15 min. The 
supernatant suspension from this step was centrifuged 
at 100,000 g for 60 min. The pellet obtained (crude 
microsomal fraction) was resuspended in 0.32 M 
sucrose and centrifuged at 15,000 g for 15 min. The 
pellet was discarded and the supernatant centrifuged 
at 100,000 g for 60 min. The pellet from this step 
(purified microsomal fraction) was resuspended in 
0.32 M sucrose containing 1 mM EDTA to give a final 
concentration of about 5 mg of protein per ml. The 
crude mitochondrial fraction was resuspended in 0.32 
M sucrose, layered over a discontinuous gradient 
(1.2, 1 .Q and 0.75 M sucrose) and centrifuged at 
100,000 g for 60 min. The fractions MI (between 0.32 
and 0.75 M), M, (between 0.75 and 1 .O M) and M3 
(between 1 .O and 1.2 M) were collected and resuspend- 
ed in 0.32 M sucrose containing 1 mM EDTA to give a 
concentration of about 5 mg of protein per ml. Protein 
in subcellular fractions was determined by the method 
of Lowry et al. [14] . 
The appropriate amounts of ceramide and detergent 
solutions in chloroform-methanol (2: 1) were mixed 
and dried in tubes before addition of other compo- 
nents of the incubation mixture. The reaction was 
stopped with chloroform-methanol (2: 1 v/v, 10 vol.) 
and carrier glycolipids were added. The solution was 
partitioned by the addition of water (1 vol.) and the 
lower phase washed twice with chloroform-methanol- 
water (3:48:47, v/v), For determination of the total 
radioactivity, an aliquot of the lower phase was dried 
in the counting vial before the addition of the scin- 
tillation fluid. For the radioactivity measurement of 
individual glycolipids, an aliquot of the lower phase 
was chromatographed on thin-layer plates as described 
previously [S, 71 and the corresponding zones of ad- 
sorbant were scraped directly into counting vials. 
Radioactivity was determined by a liquid scintillation 
spectrometer (ABAC SL 40, Intertechnique, France). 
3. Results and discussion 
After incubation of UDP-galactose-1% and HFA. 
ceramide with control and Jimpy brain homogenates 
(table l), most of the lipid radioactivity was found in 
the fraction corresponding to galactocerebrosides. The 
incorporation of galactose-14C was much lower with 
Jimpy brain homogenates. 
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The subcellular distribution of the enzyme activity 
is shown in table 2. The highest activity was found in 
the microsomal fraction. In both normal and mutant 
mice almost all of the radioactivity incorporated into 
cerebrosides was recovered in the HFA-containing 
fraction. With the exception of the supernatant frac- 
tion in which galactosyl-ceramide transferase activity 
was virtually absent, significantly lowered values were 
obtained with subcellular fractions of Jimpy brain. 
This observation was confirmed when galactosyl- 
ceramide transferase activity was determined as a 
function of the enzyme concentrations using a 
purified microsomal fraction of control and mutant 
brain (fig. 1). 
The present results coupled with previously estab- 
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Fig. 1. Effect of the microsomal protein concentration on the 
galactosyl-ceramide transferase activity in normal and Jimpy 
mice. Incubation mixture contained (in 0.25 ml final volume): 
UDP-galactose-14C, 10 nmoles (5 nCi/pmole); MgCls, 1 pmole; 
HFAceramide, 0.25 Fmole; Triton X-100,0.65 mg; tris-HCl 
buffer, 10 Fmoles; purified microsomal fraction as indicated. 
Incubation was for 15 min at 37’. Total lipid radioactivity 
was determined. Further experimental details as given in the 
text, 
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Table 1 
Biosynthesis of glycolipids from UDP-galactose- 14C and ceramide containing hydroxy fatty acids with normal and Jimpy brain 
homogenates. 
Radioactivity incorporated (cpm) 
Homogenate 
(mg of 
urotein) 
Glucocere- 
brosides 
Galactocere- 
brosides 
Sulfatides Psychosine 
1 
N JP 
2 0 0 
3 0 0 
Abbreviations: N, normal mice; Jp, Jimpy mice. 
N JP 
1356 241 
2155 414 
N JP 
114 14 
191 24 
N JP 
9 0 
18 0 
The reaction mixture contained (in 0.5 ml final volume): UDPgalactose- 14C, 20 nmoles (5 &i/pmole);MgClz, 2 pmoles; HFA- 
ceramide, 0.75 pmole;Triton X-100, 1.5 mg; tris-HCl buffer, 20 pmoles (pH 7.3); 10% brain homogenate of 15day old mice in 
0.05 M tiis-HCl (pH 7.3) as indicated. Incubation was for 90 min at 37O. Glycolipids were separated by TLC on the borate impreg- 
nated plates [ 51. Further incubation conditions and the enzyme assay were as described in the text. 
lished deficiency of psychosine synthesis [7,7] may 
lead to a conclusion that two different galactosyl- 
transferase activities are involLed in the metabolic 
defect of Jimpy mutation. These findings, in addition 
to other enzymatic defects reported in Jimpy brain 
[ 15, 161, would be in accordance with the hypothesis 
of a multi-enzymatic deficiency in mutant CNS that 
we proposed earlier [8] . However, a more complete 
characterization of two galactosyltransferase activities 
which bring out in vitro synthesis of psychosine and 
cerebroside, respectively, will be needed to confirm 
the existence of two different enzymes. 
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Table 2 
Distribution of galactosyl-ceramide transferase activity in subcellular fractions of normal and Jimpy mice. 
Radioactivity incorporated 
Source 
(cpm/mg protein) 
-____- 
of 
enzyme 
HFA-galactocerebrosides NFA-galactocerebrosides 
N JP N JP 
Homogenate 205 38 4 2 
Ml 726 104 5 26 
M2 211 58 3 0 
M3 161 85 4 7 
Microsomes 1688 198 12 6 
Supernatant 0 10 5 0 
Abbreviations: N, normal mice; Jp, Jimpy mice. 
The incubation mixture contained (in 0.5 ml final volume): UDP-galactose-14C, 10 nmoles (5 pCi/pmole); MgCl2, 2 pmoles; HFA- 
ceramide, 0.50 rmolet, Triton X-100, 1.3 mg; tris-HCl buffer, 20 pmoles (pH 7.3); enzyme source, 1.0 mg of protein. Incubation 
was for 120 min at 37 . Before the radioactivity determination glycolipids were separated by TLC [7]. Further experimental de- 
tails as given in the text. 
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